Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Pall Opens Life Sciences Center

By Drug Discovery Trends Editor | September 28, 2012

Pall Corporation, a global leader in filtration, separation and purification, announced it will be opening a Life Sciences Center of Excellence in Westborough, Massachusetts. Strategically located in the heart of Massachusetts’ renowned life-science cluster, the new center will provide Pall life sciences customers in the northeast region of the United States a range of process solutions for drug development, validation support and training capabilities. The new Life Sciences center is scheduled to open in the spring of 2013.

“Our New England Life Sciences Center of Excellence is an important addition to our global network of customer support centers,” said Ken Frank, President, Pall BioPharmaceuticals. “It will complement our new center in Menlo Park, Calif. and serve as a technical hub for our Life Sciences business and operations in the northeast region of the United States.”

The 113,000 square-feet center will be equipped with new advanced life sciences equipment and will serve as a showcase for Pall technologies. These include: single-use systems (SUS), tangential flow filtration (TFF) systems, viral clearance and cell culture solutions, chromatography systems and others. The Westborough complex will serve as a proving ground for new technologies and applications development and will be designed to lead customers through the sequential stages of process flow. The center also will serve as a training facility for both Pall employees and customers.

Pall plans to transfer its existing operations and employees from its Northborough, Massachusetts location to the new center.

“The new Westborough facility provides an excellent opportunity for growth and will allow us to retain and attract talented scientists and engineers from the New England area,” adds Frank.

Date: September 20, 2012
Source: Pall Corporation


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE